{
    "clinical_study": {
        "@rank": "82264", 
        "arm_group": [
            {
                "arm_group_label": "Vapocoolant spray", 
                "arm_group_type": "Experimental", 
                "description": "Vapocoolant is administered in 20 centimeters distance for 20 seconds to the patients as anesthetic before ABG."
            }, 
            {
                "arm_group_label": "Water spray", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The Patients in this arm will receive water spray as anesthetic before ABG."
            }
        ], 
        "brief_summary": {
            "textblock": "This study was aimed to compare pain levels from arterial blood gas (ABG) sampling performed\n      with vapocoolant spray in comparison to placebo."
        }, 
        "brief_title": "Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Puncture Site Pain", 
        "detailed_description": {
            "textblock": "Previous studies of vapocoolant sprays for reducing pain were mainly on venopuncture with\n      inconsistent results. There was only one prospective open labeled controlled study on\n      arterial blood gas sampling with ethyl chloride which did not show effectiveness. This study\n      will assess the efficacy and tolerability of a topical alkane vapocoolant spray for arterial\n      puncture in adults in comparison to control spray."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age of 14 years or older,\n\n          -  needs ABG as a part of their diagnosis\n\n        Exclusion Criteria:\n\n          -  history of analgesic medication used within 24 hours of enrollment,\n\n          -  any sign of decreased consciousness,\n\n          -  history of skin hypersensitivity,\n\n          -  inability to report a pain score,\n\n          -  history of a known neurological problem that changes pain perception,\n\n          -  history of cold related reactions (e.g. Raynaud's phenomenon, cold urticaria),\n\n          -  abnormal Allen's test"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860248", 
            "org_study_id": "TUMS 4341"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vapocoolant spray", 
                "description": "The Vapocoolant spray containing alkane is applied for 20 seconds.", 
                "intervention_name": "Vapocoolant spray", 
                "intervention_type": "Drug", 
                "other_name": "Cryoanesthetic"
            }, 
            {
                "arm_group_label": "Water spray", 
                "description": "This spray is covered so the patient and the investigator can not find the spray type out.", 
                "intervention_name": "Water spray", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "vapocoolant effectiveness", 
            "arterial puncture"
        ], 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Imam Khomeini hospital complex"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Topical Alkane Vapocoolant Spray Effectiveness On Arterial Puncture Pain Reduction In Emergency Department: Randomized Double Blind Placebo-Controlled Trial", 
        "overall_official": {
            "affiliation": "Tehran University of Medical Sciences", 
            "last_name": "Shervin Farahmand, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "30 seconds after ABG was performed, the patients would be asked about the puncture pain in verbal numerical pain scale.", 
            "measure": "puncture pain", 
            "safety_issue": "No", 
            "time_frame": "30 seconds after ABG"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860248"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "30 seconds after ABG was performed, the patients would be asked about the spray application pain in verbal numerical pain scale.", 
                "measure": "Vapocoolant application pain", 
                "safety_issue": "No", 
                "time_frame": "30 seconds affter procedure completion"
            }, 
            {
                "description": "The number of ABG sampling attempts is recorded 30 seconds after procedure.", 
                "measure": "number of puncture attempts", 
                "safety_issue": "No", 
                "time_frame": "30 seconds after procedure"
            }
        ], 
        "source": "Tehran University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tehran University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}